4TEEN4 begins trial of antibody therapy for cardiogenic shock

23rd July 2025 Uncategorised 0

First patient dosed in phase 1b/2a study of procizumab

More: 4TEEN4 begins trial of antibody therapy for cardiogenic shock
Source: News